ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,000 | -12.5% | 973 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -57.9% | 973 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -13.6% | 973 | +15.1% | 0.00% | – |
| Q2 2018 | $22,000 | +10.0% | 845 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | -31.0% | 845 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | +61.1% | 845 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | -28.0% | 845 | -41.2% | 0.00% | – |
| Q2 2017 | $25,000 | 0.0% | 1,438 | +1.8% | 0.00% | – |
| Q1 2017 | $25,000 | +38.9% | 1,413 | +33.1% | 0.00% | – |
| Q4 2016 | $18,000 | +12.5% | 1,062 | +6.0% | 0.00% | – |
| Q3 2016 | $16,000 | +14.3% | 1,002 | +7.2% | 0.00% | – |
| Q2 2016 | $14,000 | +27.3% | 935 | +23.7% | 0.00% | – |
| Q1 2016 | $11,000 | -45.0% | 756 | +8.5% | 0.00% | – |
| Q4 2015 | $20,000 | +81.8% | 697 | +5.6% | 0.00% | – |
| Q3 2015 | $11,000 | -31.2% | 660 | +9.5% | 0.00% | – |
| Q2 2015 | $16,000 | – | 603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |